In this final section of our review, we discuss a variety of skin disorders often acquired during hospitalization in the intensive care unit. Environmental, nutritional, immunologic, and pharmacologic factors, among others, place patients at risk for drug eruptions, including leukocytoclastic vasculitis and anticoagulant-induced necrosis; moniliasis; acquired zinc deficiency; recurrent herpes simplex labialis; seborrheic dermatitis; contact dermatitis; and pressure sores.
Get full access to this article
View all access options for this article.
References
1.
Arndt KA, Jick H.Rates of cutaneous reactions to drugs. A report from the Boston Collaborative Drug Surveillance Program. JAMA1976;235:918-923
2.
Shapiro S., Slone D., Siskin V., et al. Drug rash with ampicillin and other penicillins. Lancet1969;2:969-972
3.
Kauppinen K. , Staubb S.Causative agents and clinical types. A series of in-patients during a 10-year period. Acta Derm Venereol1984;64:320-324
4.
Van Arsdel PPAdverse drug reactions. In: Middletown E Jr , Reed CF, Ellis EF, eds. Allergy: principles and practice. St. Louis: CV Mosby1978:1133
5.
Kuokkanen K.Drug eruptions: a series of 464 cases in the Department of Dermatology, University of Turku, Finland, during 1966-1967 . Acta Allergol1972;27:407-438
6.
Wintroub BU, Shiffman NJ, Arndt KAAdverse cutaneous reactions to drugs. In: Fitzpatrick TB, ed. Dermatology in general medicine. New York: McGraw-Hill, 1979:558-567
7.
Wintroub BU, Stern R.Cutaneous drug reactions: pathogenesis and clinical classification . J Am Acad Dermatol1985;13:167-179
8.
Van Arsdel PP Jr.Allergy and adverse drug reactions. J Am Acad Dermatol1982;6:833-845
9.
Hood AF, Haynes HAMucocutaneous complications of cancer chemotherapy. In: Fitzpatrick DB, et al, eds. Update: dermatology and general medicine. New York: McGraw-Hill, 1983:80-97
10.
Bronner AK, Hood AFCutaneous complications of chemotherapeutic agents. J Am Acad Dermatol1983;9:645-663
11.
Lee SL, Chase PHDrug-induced systemic lupus erythematosus: a critical review. Semin Arthritis Rheum1975;5:83-103
12.
Storrs FJUse and abuse of systemic corticosteroid therapy. J Am Acad Dermatol1979;1:95-105
13.
Brehmer-Anderson E., Pederson NBSweat gland necrosis and bullous skin changes in acute drug intoxication. Acta Derm Venereol1969;49:157-162
14.
Sams WM Jr.Necrotizing vasculitis. J Am Acad Dermatol1980;3:1-13
15.
Fauci AS, Haynes BF, Katz P.The spectrum of vasculitis: clinical, pathologic, immunologic, and therapeutic considerations. Ann Intern Med1978;89: 660-676
16.
Callen JPCutaneous vasculitis: a systemic disease. In: Callen JP, et al, eds. Current issues in dermatology. Boston: GK Hall, 1981:23-42
17.
Sams WM Jr, Thorne FG, Small P., et al. Leukocytoclastic vasculitis . Arch Dermatol1976;112:219-226
18.
Braverman IM , Yen A.Demonstration of immune complexes in spontaneous and histamine-induced lesions and in normal skin of patients with leukocytoclastic angiitis. J Invest Dermatol1975;64:105-112
19.
Gower RG, Sams WM Jr, Thorne EG, et al. Leukocytoclastic vasculitis: sequential appearance of immunoreactants and cellular changes in serial biopsies. J Invest Dermatol1977;69:477-484
Fauci AS, Katz P., Haynes BF, et al. Cyclophosphamide therapy of severe systemic necrotizing vasculitis . N Engl J Med1979;301:235-238
22.
Wallace DJ, Goldfinger D., Thompson-Breton R., et al. Advances in the use of therapeutic pheresis for the management of rheumatic diseases. Semin Arthritis Rheum1980;10:81-91
23.
Lockwood CM, et al. Reversal of impaired splenic function in patients with nephritis or vasculitis (or both) by plasma exchange. N Engl J Med1979; 300:524-530
24.
Levine LE, Bernstein JE, Soltani K., et al. Heparin-induced cutaneous necrosis unrelated to injection sites. A sign of potentially lethal complications. Arch Dermatol1983;119:400-403
25.
Faraci PA, Deterling RA, Stein AM, et al. Warfarin induced necrosis of the skin. Surg Gynecol Obstet1978;146:695-700
26.
Slutzki S., Bogokowsky H., Gilboa Y., et al. Coumadin-induced skin necrosis. Int J Dermatol1984;23:117-119
27.
Shelley WB, Saven U.Heparin necrosis: an anticoagulant-induced cutaneous infarct. J Am Acad Dermatol1982;7:674-677
28.
Kelly RA, Gelfand JA, Pincus SHCutaneous necrosis caused by systemically administered heparin. JAMA1981;246:1582-1583
29.
Nalbandian RM, Beller FK, Kamp AK, et al. Coumarin necrosis of skin treated successfully with heparin. Obstet Gynecol1971;38:395-399
30.
DiCatto M., Ellman I.Coumadin-induced necrosis of breast, disseminated intravascular coagulation, and hemolytic anemia. Ann Intern Med1975;83:233-234
31.
Horn JR, Danziger LH, Davis RJWarfarin-induced skin necrosis: report of four cases. Am J Hosp Pharm1981;38:1763-1768
32.
Jones RR, Cunningham J.Warfarin skin necrosis: the role of factor VII. Br J Dermatol1979;101:561-565
33.
Cimo PL, Moake JL, Weinger RS, et al. Heparin-induced thrombocytopenia: association with a platelet aggregating factor and arterial thromboses. Am J Hematol1979;6:125-133
34.
Jackson AM, Pollock AVSkin necrosis after heparin injection. Br Med J1981;283:1087-1088
35.
Franson TR, Rose HD, Spivey MR, et al. Late-onset, warfarin-caused necrosis occurring in a patient with infectious mononucleosis. Arch Dermatol1984; 120:927-931
36.
Horn JR, Danzinger LH, Davis RJSubcutaneous heparin as a cause of skin necrosis. Am J Hosp Pharm1982;39:417-418
37.
Bell WR, Royall RMHeparin-associated thrombocytopenia: a comparison of three heparin preparations . N Engl J Med1980;303:902-907
38.
White PW, Sadd JR, Nensel REThrombotic complications of heparin therapy including six cases of heparin-induced skin necrosis. Am Surg1979 ; 190:595-607
39.
Scandling J. , Walker BKExtensive tissue necrosis associated with warfarin sodium therapy. South Med J1980;73:1470-1472
40.
Tuneau A., Moreno A., de Moragas JMCutaneous reactions secondary to heparin injections. J Am Acad Dermatol1985;12:1072-1077
41.
Hussey CV, Bernhard VM, McLean MR, et al. Heparin-induced platelet aggregation: in vitro confirmation of thrombotic complications associated with heparin therapy. Ann Clin Lab Sci1979;9: 487-493
Hall JC, McConahay D., Gibson D., et al. Heparin necrosis: an anticoagulation syndrome. JAMA1980; 244:1831-1832
44.
Montes LF, Wilborn WHFungus-host relationship in candidiasis: a brief review. Arch Dermatol1985; 121:119-124
45.
Eaglstein WH , Pariser DMOffice techniques for diagnosing skin disease . Chicago : Year Book, 1978:11
46.
Abramowicz M, et al, eds. New topical antifungal drugs. Med Lett Drugs Ther1983;25:98-100
47.
Smith EBTopical antifungal agents. Dermatol Clinics1984;2:109-113
48.
Petersen EA , Alling DW, Kirkpatrick CHTreatment of chronic mucocutaneous candidiasis with ketoconazole. Ann Intern Med1980;93:791-795
49.
Henry JCKetoconazole. Dermatol Clinics1984 ; 2:121-128
50.
Tashjian LS , Peacock JELaryngeal candidiasis. Report of seven cases and review of the literature. Arch Otolaryngol1984;110:806-809
51.
Epstein JB, Truelove EL, Izutzu KTOral candidiasis: pathogenesis and host defense. Rev Infect Dis1984;6:96-106
52.
Bodey GP, Luna M.Skin lesions associated with disseminated candidiasis. JAMA1974;229:1466-1468
53.
Grossman ME , Silvers DN, Walther RRCutaneous manifestations of disseminated candidiasis . J Am Acad Dermatol1980;2:111-116
54.
Edwards JE Jr, Lehrer RI, Stiehm ER, et al. Severe candidal infections. Clinical perspective, immune defense mechanisms, and current concepts of therapy . Ann Intern Med1978;89:91-106
55.
Medoff G., Kobayashi G.Strategies in the treatment of systemic fungal infections. N Engl J Med1980;3:145-155
56.
Levine HB, ed. Ketoconazole in the management of fungal disease. New York: ADIS Press, 1982:116-118
57.
Levine HB, ed. Ketoconazole in the management of fungal disease. New York: ADIS Press, 1982:141-144
58.
Bernstein B. , Leyden JJZinc deficiency and acrodermatitis after intravenous hyperalimentation. Arch Dermatol1978;114:1070-1072
Hansen RC, Lemen R., Revsin B.Cystic fibrosis manifesting with acrodermatitis and enteropathica-like eruption. Association with essential fatty acid and zinc deficiencies. Arch Dermatol1983;119:51-55
61.
Ferrandiz C. , Henkes J., Peyri J., et al. Acquired zinc deficiency syndrome during total parenteral alimentation. Clinical and histopathological findings . Dermatologica1981;163:255-266
62.
Brazin SA, Johnson WT, Abramson LJThe acrodermatitis enteropathica-like syndrome. Arch Dermatol1979;115:597-599
63.
Norris D.Zinc and cutaneous inflammation. Arch Dermatol1985;121:985-989
64.
Strobel CT, Byrne WJ, Abramovits W., et al. A zinc-deficiency dermatitis in patients on total parenteral nutrition. Int J Dermatol1978;17:575-581
Spruance SL , Overall JC Jr, Kern ER, et al. The natural history of recurrent herpes simplex labialis. Implications for antiviral therapy . N Engl J Med1977;297:69-75
67.
Nahmias AJ, Roizman B.Infection with herpes-simplex viruses 1 and 2. N Engl J Med1973;289: 719-725
68.
Pazin GJ, Armsrrong JA, Lam MT, et al. Prevention of reactivated herpes simplex infection by human leukocyte interferon after operation on the trigeminal root. N Engl J Med1979;301:225-230
69.
Cheeseman SH , Rubin RH, Stewart JA, et al. Controlled clinical trial of prophylactic human-leukocyte interferon in renal transplantation. Effects on cytomegalovirus and herpes simplex virus infections. N Engl J Med1979;300;1345-1349
70.
Saral R., Burns WH, Laskin OL, et al. Acyclovir prophylaxis of herpes-simplex-virus infections: a randomized double-blind, controlled trial in bone-marrow-transplant recipients . N Engl J Med1981; 305:63-67
71.
Gluckman E. , Lotsburg J., Devergie A., et al. Prophylaxis of herpes infections after bone-marrow transplantation by oral acyclovir. Lancet1983;2:706-708
72.
Lindgren KM , Douglas RG Jr, Couch RBSignificance of herpesvirus hominis in respiratory secretions of man. N Engl J Med1968;278:517-523
73.
Daniels CA, LeGoff SG, Notkins ALShedding of infectious virus/antibody complexes from vesicular lesions of patients with recurrent herpes labialis. Lancet1975;2:524-528
Eaglstein WH , Pariser DMOffice techniques for diagnosing skin disease . Chicago: Year Book, 1978:1-7, 9-15, 84, 91-110
84.
Skinner RB Jr, Noah PW, Taylor RM, et al. Double-blind treatment of seborrheic dermatitis with 2% ketoconazole cream. J Am Acad Dermatol1985; 12:852-856
85.
Fisher AAContact dermatitis. Philadelphia: Lea and Febiger, 1978:170-171
86.
Fisher AADermatologic hazards of electrocardiography. Cutis1977;20:686-695
87.
Fisher AAContact dermatitis. Philadelphia: Lea and Febiger, 1978:39-70
88.
Fisher AAAllergic dermatitis medicamentosa: the "systemic contact-type variety ." Cutis1976;18:637-642
89.
Marks JGAllergic contact dermatitis to povidoneiodine. J Am Acad Dermatol1982;6:473-475
90.
Hendricks AA , Dec GW Jr.Contact dermatitis due to nitroglycerin ointment. Arch Dermatol1979;115: 853-855
91.
Fisher AAThe management of propylene glycol-sensitive patients. Cutis1980;25:27-44
92.
Andersen KE , Kvorning SAMedical aspects of the decubitus ulcer. Int J Dermatol1982;21:265-270
93.
Reuler JB, Cooney TGThe pressure sore: pathophysiology and principles of management. Ann Intern Med1981;94:661-666
94.
Staas WE Jr, LaMantia JGDecubitus ulcers and rehabilitation medicine . Int J Dermatol1982;21:437-444
95.
Sather MR, Weber CE Jr, George J.Pressure sores and the spinal cord injury patient. Drug Intell Clin Pharm1977;11:154-169
96.
Witkowski JA , Parish LCHistopathology of the decubitus ulcer. J Am Acad Dermatol1982;6:1014-1021
97.
El-Toraei I. , Chung B.The management of pressure sores . J Dermatol Surg Oncol1977;3:507-511
98.
Sugarman B. , Hawes S., Musher DM, et al. Osteomyelitis beneath pressure sores . Arch Intern Med1983 ;143:683-688
99.
Sugarman B. , Brown D., Musher D.Fever and infection in spinal cord injury patients. JAMA1982; 248:66-70
100.
Hentz VRManagement of pressure sores in a specialty center. A reappraisal . Plast Reconstr Surg1979;64:683-691
Galpin JE, Chow AW, Bayer AS, et al. Sepsis associated with decubitus ulcers. Am J Med1976;61:346-350
103.
Yarkony GM , Kramer E., King R., et al. Pressure sore management: efficacy of a moisture reactive occlusive dressing. Arch Phys Med Rehabil1984;65:597-600
104.
Parish LC, Collins E.Decubitus ulcers: a comparative study. Cutis1979;23:106-110
105.
Parish LC, Witkowski JAClinitron therapy and the decubitus ulcer: preliminary dermatologic studies . Int J Dermatol1980;19:517-518
106.
Almeyda J. , Levantine A.Cutaneous reactions to cardiovascular drugs . Br J Dermatol1973;83:313-319
107.
Huff JC, Weston WL, Tonneson MGErythema multiforme: a critical review of characteristics, diagnostic criteria, and causes. J Am Acad Dermatol1983 ;8:763-775
108.
Swinyer LJDetermining the cause of drug eruptions. Dermatol Clin1983;1:417-431
Herschthal D., Robinson MJBlisters of the skin in coma induced by amitriptyline and clorazepate dipotassium. Report of a case with underlying sweat gland necrosis. Arch Dermatol1979;115:499
134.
Fisher AADermatologic hazards of electrocardiography. Cutis1977;20:686-695
135.
Heng MCY . Lithium carbonate toxicity: acneform eruption and other manifestations. Arch Dermatol1982 ;118:246-248
136.
Bakris GL, Smith DW, Timari S.Dermatologic manifestations of lithium: a review. Int J Psychiatry Med1980;10:327-331
137.
Schlappner OLA , Shelley WB, Ruberg RL, et al. Acute papulopustular acne associated with prolonged intravenous hyperalimentation. JAMA1972; 219:877-880
138.
Bernstein B., Leyden JJZinc deficiency and acrodermatitis after intravenous hyperalimentation. Arch Dermatol1978;114:1070-1072
139.
Stern RS, Bigby M.An expanded profile of cutaneous reactions of non-steroidal anti-inflammatory drugs. Reports to a specialty-based system for spontaneous reporting of adverse reactions to drugs. JAMA1984;252:1433
140.
Smith FE, Lindberg PJLife-threatening hypersensitivity to sulindac. JAMA1980;244:269-270
141.
McCall CY, Cooper JWTolmetin anaphylactoid reaction . JAMA1980;243:1263
142.
Burrish GF , Katz BLSulindac-induced anaphylaxis. Ann Emerg Med1981;19:154-155
